Member news

PHARMExcel is celebrating recognition of TOP UK CRO wholeheartedly as an acknowledgement of its efforts to create a distinctive niche in the Contract Research Organisation (CRO) industry, one which balances the commercial and scientific objectives of the biotech/researcher with the practical clinical trial delivery challenges and positive patient outcomes.

This is the first-ever autoimmunity study to evaluate a potential functional cure that targets the antigenic source – the origin of autoimmune disease.

First non-hormonal menopause treatment approved for use in the UK by the MHRA, with early-stage development at Stevenage Bioscience Catalyst

Research conducted by Pioneer Group in collaboration with Beauhurst into the UK life sciences landscape reveals a growing trend of investment into more mature companies.

Discovery Park has partnered with global proptech leader Equiem to launch Discover More — a purpose-built app that redefines how people work, connect, and collaborate across the 220-acre site. Home to over 180 pioneering companies working across science and technology, the new app is designed to make every tenant’s day-to-day experience more efficient and better connected, supporting an active tenant community and innovation ecosystem.

Microbiotica announces that patient recruitment is complete in its Phase 1b First-in-Human trial, COMPOSER-1, of MB310 in ulcerative colitis (UC) patients.

Cotton Mouton Diagnostics (CMD), a cutting-edge UK-based diagnostics technology company, has received a half-a-million-pound investment from CPI Enterprises as part of the Innovate UK Catapult Investment Pilot.

Brainomix, a global leader in AI-powered imaging solutions in stroke and lung fibrosis, has announced the appointment of Anna Griffin as Chief Financial Officer, filling a key leadership role within the company following its recent £14 million Series C funding round.

Rosalind brings extensive leadership experience across the health and life sciences sector. She has led the Government’s Office for Life Sciences for the last four years, bringing together the Government, the NHS, academia and industry to drive improved patient outcomes and economic growth through life sciences.

LIfT BioSciences ('LIfT' or 'the Company')today announces a grant of €12 million has been awarded from Ireland's Disruptive Technologies Innovation Fund

Members of the Industry Skills Accelerator (ISA) have celebrated a successful year of strengthening the UK’s medicines manufacturing workforce.

CGT Catapult, an independent technology and innovation organisation specialising in the advancement of the cell and gene therapy industry, has appointed Dr Jim Faulkner as its new Chairman, effective from 29th July 2025.

The UK government has officially launched its landmark Life Sciences Sector Plan, backed by over £2 billion in public funding and spearheaded by the Department for Science, Innovation and Technology, Business and Trade, and Health and Social Care.

Brandon Capital, Australasia’s leading life sciences venture capital firm, today announced the final close of its sixth fund at A$439 million.

The Milner Therapeutics Institute is delighted to be featured in a new report celebrating a decade of partnership and impact between AstraZeneca and the University of Cambridge.

Cell and Gene Therapy Catapult (CGT Catapult), an independent technology and innovation organisation specialising in the advancement of the cell and gene therapy industry, has appointed Dr Ed Samuel as its Chief Operations Officer (COO).

Pioneer Group and Science Creates today announce a new partnership that will support the next generation of science and technology ventures across the UK and Ireland.

Logical Biological, biospecimen and critical material experts, today announced the launch of a new sister company, Logical Antigen, focused on rapid and customised delivery of high-quality antigens and biologicals, for research and manufacturing of diagnostic products.

PIR International recently partnered with Sibylla Biotech in appointing Dieter Weinand as Non-Executive Chair.

Construction of Europe’s tallest and most technically sophisticated purpose-built commercial lab building has started on site at Canary Wharf, London.